Evolution of patients with Sézary syndrome after mogamulizumab discontinuation for any cause except progression: a multicentre retrospective study (Moga-stop Study).

Autor: Tzoumpa S; Department of Dermatology, Henri-Mondor University Hospital, AP-HP, Créteil, France., Ingen-Housz-Oro S; Department of Dermatology, Henri-Mondor University Hospital, AP-HP, Créteil, France.; Paris Est Créteil University, EpiDermE, Créteil, France.; French Cutaneous Lymphomas Study Group (GFELC), France., de Masson A; French Cutaneous Lymphomas Study Group (GFELC), France., Pham-Ledard A; French Cutaneous Lymphomas Study Group (GFELC), France., El Aarbaoui T; Paris Est Créteil University, EpiDermE, Créteil, France., Dereure O; French Cutaneous Lymphomas Study Group (GFELC), France., Quereux G; French Cutaneous Lymphomas Study Group (GFELC), France., Faiz S; French Cutaneous Lymphomas Study Group (GFELC), France., de Vicq de Cumptich M; French Cutaneous Lymphomas Study Group (GFELC), France., Ram-Wolff C; French Cutaneous Lymphomas Study Group (GFELC), France., Janela-Lapert R; French Cutaneous Lymphomas Study Group (GFELC), France., Guenova E; French Cutaneous Lymphomas Study Group (GFELC), France., Lheure C; French Cutaneous Lymphomas Study Group (GFELC), France., Le Corre Y; French Cutaneous Lymphomas Study Group (GFELC), France., Adamski H; French Cutaneous Lymphomas Study Group (GFELC), France., Blanchard M; French Cutaneous Lymphomas Study Group (GFELC), France., Bonnet N; French Cutaneous Lymphomas Study Group (GFELC), France., Amatore F; French Cutaneous Lymphomas Study Group (GFELC), France., Grange F; French Cutaneous Lymphomas Study Group (GFELC), France., Troin L; French Cutaneous Lymphomas Study Group (GFELC), France., Bagot M; French Cutaneous Lymphomas Study Group (GFELC), France., Beylot-Barry M; French Cutaneous Lymphomas Study Group (GFELC), France.

Publikováno v: The British journal of dermatology [Br J Dermatol] 2024 Jun 20; Vol. 191 (1), pp. 143-144.